Bayesian Pharmacokinetically Guided Dosing of Paclitaxel in Patients With Non-Small Cell Lung Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-03-0060
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Pharmacokinetically Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2014English

Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Single‐Agent Paclitaxel in the Treatment of Advanced Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
1999English

Quality of Life in Patients With Non-Small Cell Lung Cancer

Vojnosanitetski Pregled
MedicinePharmacology
2017English

Vorinostat Increases Carboplatin and Paclitaxel Activity in Non-Small Cell Lung Cancer Cells

International Journal of Cancer
Cancer ResearchOncology
2010English

HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

Circadian Function in Patients With Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Prognosis of Non-Small-Cell Lung Cancer in Patients With Idiopathic Pulmonary Fibrosis

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy